𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Chromosomal alterations in human pancreatic endocrine tumors

✍ Scribed by Erik Stumpf; Yan Aalto; Anders Höög; Magnus Kjellman; Timo Otonkoski; Sakari Knuutila; Leif C. Andersson

Publisher
John Wiley and Sons
Year
2000
Tongue
English
Weight
77 KB
Volume
29
Category
Article
ISSN
1045-2257

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Genomic imbalances in the progression of
Genomic imbalances in the progression of endocrine pancreatic tumors
✍ Jianming Zhao; Holger Moch; Alexander F. Scheidweiler; Angela Baer; Alejandro A. 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 200 KB

## Abstract Endocrine pancreatic tumors (EPTs) are neoplasms with malignant potential. To explore the molecular basis of metastatic progression in human EPTs, we analyzed 17 paired specimens of primary EPTs and their metastases and 28 nonmetastatic EPTs using comparative genomic hybridization (CGH)

Genetic alterations on 3p, 11q13, and 18
Genetic alterations on 3p, 11q13, and 18q in nonfamilial and MEN 1-associated pancreatic endocrine tumors
✍ Ola Hessman; Daniel Lindberg; Annika Einarsson; Peter Lillhager; Tobias Carling; 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 163 KB 👁 1 views

Pancreatic endocrine tumors occur sporadically and as part of the multiple endocrine neoplasia type 1 (MEN 1) and von Hippel-Lindau (VHL) syndromes. The MEN1 locus on 11q13 and a candidate tumor suppressor locus on 3p are known to be hemi-or homozygously mutated in a subset of these tumors. Chromoso

Allelic alterations in well-differentiat
Allelic alterations in well-differentiated neuroendocrine tumors (carcinoid tumors) identified by genome-wide single nucleotide polymorphism analysis and comparison with pancreatic endocrine tumors
✍ Do Ha Kim; Yasuhiko Nagano; In-Seon Choi; Jill A. White; James C. Yao; Asif Rash 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 427 KB

## Abstract Well‐differentiated neuroendocrine tumors (WDNT, carcinoid tumors) are uncommon indolent neoplasms. The genetic alterations of these tumors are not well characterized. We used genome‐wide high‐density single nucleotide polymorphism (SNP) array analysis to detect copy number alterations

Asbestos, chromosomal deletions, and tum
Asbestos, chromosomal deletions, and tumor suppressor gene alterations in human malignant mesothelioma
✍ Siva S. Murthy; Joseph R. Testa 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 138 KB 👁 2 views

Exposure to the carcinogen asbestos is considered to be a major factor contributing to the development of most malignant mesotheliomas (MMs). We highlight the role of asbestos in MM and summarize cytogenetic and molecular genetic findings in this malignancy. The accumulation of numerous clonal chrom

Molecular alterations to human chromosom
Molecular alterations to human chromosome 3p loci in neuroendocrine lung tumors
✍ Albert Kovatich; David M. Friedland; Teresa Druck; Piotr Hadaczek; Kay Huebner; 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 850 KB

## Background: The origins of and interrelations between low grade and high grade neuroendocrine lung tumors, typical and atypical carcinoids, and small cell lung carcinoma (sclc) have not been elucidated. karyotypic and molecular genetic studies have demonstrated deletions in 3p in 100% of sclcs a